最近在糖解过程中的进展与瘤转移有关
Luo Qiong1, Xiao Shuyao1, Xu Shan1
1Cancer Research Institute, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang 421001, China.
Current molecular pharmacology
|September 3, 2024
概括
癌症转移,由增加的葡萄糖分解驱动,可以通过抑制这种代谢过程来向. 非编码RNA,信号通路和转录因子是瘤扩散中的糖解的关键调节者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 癌症转移是癌症死亡的主要原因.
- 增加的葡萄糖分解 (Warburg效应) 助长癌细胞的生长,入侵和瘤的扩散.
- 向有氧糖解是一种有希望的抗癌治疗策略.
研究的目的:
- 阐明瘤转移中的糖溶解机制.
- 研究非编码RNA,信号通路和转录因子在这个过程中的作用.
- 探索它们作为癌症治疗的预后标志物和治疗点的潜力.
主要方法:
- 关于糖解,瘤转移和相关分子机制的当前文献的综述.
- 分析非编码RNAs (miRNAs, lncRNAs, circRNAs) 作为竞争性内源RNAs (ceRNAs) 的参与.
- 检查关键信号通路 (PI3K/AKT,HIF,Wnt/β-Catenin,ERK) 和转录因子在糖溶解驱动的转移.
主要成果:
- 非编码RNA显著影响葡萄糖代谢和瘤扩散.
- lncRNAs和circRNAs作为ceRNAs起作用,调节miRNA活动和基因表达.
- 信号通路和转录因子是糖解介导瘤转移的组成部分.
结论:
- 非编码RNA,信号通路和转录因子是瘤转移中的糖解的关键调节者.
- 这些因素具有作为预后生物标志物和治疗点的潜力.
- 包括传统中医药和西方药物在内的研究疗法在抑制通过糖解路径的瘤扩散方面表现有前途.
更多相关视频
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


